SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-004338
Filing Date
2017-05-15
Accepted
2017-05-15 16:20:29
Documents
52
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20170331x10q.htm 10-Q 1631581
2 EX-10.1 edit-20170331ex1013d1533.htm EX-10.1 1010200
3 EX-31.1 edit-20170331ex3116f59b8.htm EX-31.1 18628
4 EX-31.2 edit-20170331ex31230a88f.htm EX-31.2 18205
5 EX-32.1 edit-20170331ex3217021aa.htm EX-32.1 13589
  Complete submission text file 0001558370-17-004338.txt   6304222

Data Files

Seq Description Document Type Size
6 EX-101.INS edit-20170331.xml EX-101.INS 930169
7 EX-101.SCH edit-20170331.xsd EX-101.SCH 47816
8 EX-101.CAL edit-20170331_cal.xml EX-101.CAL 33132
9 EX-101.DEF edit-20170331_def.xml EX-101.DEF 151687
10 EX-101.LAB edit-20170331_lab.xml EX-101.LAB 400571
11 EX-101.PRE edit-20170331_pre.xml EX-101.PRE 267804
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 17844491
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences